Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Theratechnologies Inc T.TH

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  THERF

Theratechnologies Inc is a pharmaceutical company addressing unmet medical needs in metabolic disorders. EGRIFTA is its registered trademark in the USA and it is used to commercialize its first product using its internally developed compound, tesamorelin.
Price: $1.36 | Change: $-0.04 | %Change: -2.86%
Volume: 109,750 | Day High/Low: 1.41/1.35 | 52 Week High/Low: 1.49/0.325
View modes: 
0 stars

RE:insider buying update #2

The insiders have spoekn with a collective voice given the insider buying and the absence of selling.  rate and reply
0 stars

insider buying update #2

Paul Pommier, corporate director buys 50000.......Luc Tanguay, president and CEO buys 25000...........Jean-Denis Talon , corporate director buys 20000.........Lyne Fortin, senior vice president more
0 stars

RE:Paul Pommier

insiders are taking a nice stake  rate and reply
0 stars

RE:RE:Paul Pommier

I found the answer to my question The black out period starts the first day of the next quarter his purchase was made within the allowed time frame  rate and reply
0 stars

RE:Paul Pommier

He bought one week before the end of the quarter... when is the  black out period for insiders?  rate and reply
5 stars

Paul Pommier

He bought 50,000 share on the public market yesterday in the 1.38 to 1.40 range.  He wouldn't do that unless he know things are going well!!  rate and reply
0 stars

RE:RE:hold steady guys

Well then your looking in the wrong spot or your looking at the wrong stock  rate and reply
0 stars


I believe IBD would call this base on the weekly chart a "high tight flag"; very rare and very powerful. But IBD doesn't normally deal with stocks in this price range.  rate and reply
0 stars

RE:hold steady guys

I don't believe UBS sold any shares.  It was mostly TD Securities and some of the bigger trades were crosses. And even then only 156K shares were traded.  rate and reply
0 stars

hold steady guys

its just UBS trying to rock the boat on a Friday at 3pm. ITs almost time for a call to the Ontario securities commission and Irocc.  rate and reply
0 stars

RE:RE:RE:it sure has been quite

No sellers, but no buyers either.  I guess the bloomberg number were not that spectacular today... Another 7 weeks or so until 2nd quarter results.  Perhaps we'll see more interest then.  rate and reply
0 stars

RE:RE:it sure has been quite

The stock looks like it has been consolidated. There doesn't appear much left at this price. UBS must have finished selling.  rate and reply
0 stars

RE:it sure has been quite

feeling lonely buying this..  when volume returns its going to be good.......  rate and reply
0 stars

it sure has been quite

guess it needs some news.. maybe an approval  rate and reply
0 stars


Where did you go tibutch1 ??  rate and reply
0 stars

Theratechnologies shareholders elect 6 directors at AGM

2015-05-20 11:53 ET - News Release Shares issued 61,010,603 TH Close 2015-05-19 C$ 1.40 Mr. Denis Boucher reports ANNOUNCEMENTS IN CONJUNCTION WITH THERATECHNOLOGIES ANNUAL MEETING more
0 stars


The volume has really been dropping off as it consolidates.  Forming a nice ascending triangle. If we get over the 1.50 I don't think 1.75 will take long.  Should probably be trading in the 2 more
0 stars


I looked up Serostim on Bloomberg and it indicates US sales of $144 million in the last twelve months. I don't know if that is also understated verusus reality, as it is with Egrifta. But if it more
0 stars

Theratechnologies plaintiff gets court OK to drop suit

2015-05-15 11:10 ET - News Release Shares issued 61,010,603 TH Close 2015-05-14 C$ 1.35 Ms. Jocelyn Lafond reports AUTHORIZATION TO DISCONTINUE CLASS ACTION PROCEEDINGS AGAINST more
0 stars


I don't think anyone knows the answer to that. Serono sells Serostrim and I believe I heard its sales are around $200 million, some of which are probably international. It is used for much more more